Helix Biotech
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Helix Biotech is a biotechnology company that provides custom mRNA synthesis, LNP formulation development, and GMP manufacturing services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Helix Biotech Comparables
Compare Helix Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vernal Biosciences | 86% | |
| Phosphorex | 84% | |
| eTheRNA | 76% |
Helix Biotech Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 54% MoM.
- Jan 19, 2026
Monthly visitors grew 51% MoM, reaching 5K.
Helix Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Helix Biotech's valuation, stock price, and market status.
Is Helix Biotech a public or private company?
Helix Biotech is a private company.
What is the current stock price of Helix Biotech?
Helix Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Helix Biotech worth (valuation)?
Valuation information for Helix Biotech is not publicly available.
Can I buy Helix Biotech stock?
Helix Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Helix Biotech's last funding round?
Helix Biotech's most recent funding round was Series C on June 3, 2021.
Who are the main investors in Helix Biotech?
Key investors in Helix Biotech include DFJ Growth, Warburg Pincus, Sutter Hill Ventures.
Will Helix Biotech IPO soon?
No public IPO plans have been announced for Helix Biotech.
How can I track Helix Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Helix Biotech's secondary market activity and sign up for updates.